| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |